Skip to main content
ImmuneCited

Garlic 用于 Upper Respiratory Tract Infections

B

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dgarlic\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

A 12-week randomized controlled trial found the garlic group experienced 63% fewer colds, 70% shorter symptom duration, and significantly fewer viral-challenged days (111 vs 365) compared to placebo. While promising, human clinical trials remain limited.

Key Study Findings

Other n=80 3 weeks Double-blind
Investigation of the natural supplement IQP-AS-119 for the prevention of upper respiratory tract infections in …
Dose: 20.0% vs: placebo Outcome: None 效果: or 14 P=0.038

研究人群: None

Other 17.3 weeks
Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Alzheimer's disease patients

Review
Treatment of the common cold in children and adults.
Dose: None vs: None Outcome: infection rate 效果: None None

研究人群: None

Review
Chemoprevention of bladder cancer.
Dose: Various nutrients (selenium, vitamins, green tea) vs: None Outcome: Bladder cancer chemoprevention 效果: None None

研究人群: Bladder cancer patients

Meta-Analysis
Unsafe and potentially safe herbal therapies.
Dose: None vs: None Outcome: lipid levels 效果: None None

研究人群: hypertensive patients

Key Statistics

3

研究数量

300

受试者

Positive

B

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

fresh:
2-5 g raw garlic/day
general:
600-1,200 mg aged garlic extract/day

上限: No established UL; high doses may increase bleeding risk

研究中使用的剂量

剂量 持续时间 效果 N
20.0% 3 weeks Mixed 80
None 17.3 weeks Positive --
None -- Mixed --
Various nutrients (selenium, vitamins, green tea) -- Positive --
None -- Mixed --

最佳服用时间: With meals to reduce GI discomfort

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (heartburn, gas, nausea)
  • Body and breath odor
  • Increased bleeding risk
  • Allergic reactions (contact dermatitis, rare)

已知相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • HIV protease inhibitors (saquinavir — may reduce drug levels)
  • CYP2E1 substrates (garlic may alter metabolism)
  • Isoniazid (may reduce drug absorption)

可耐受最高摄入量: No established UL; high doses may increase bleeding risk

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Garlic help with Upper Respiratory Tract Infections?
Based on 3 studies with 300 participants, there is moderate evidence from clinical studies that Garlic may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Garlic should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 2-5 g raw garlic/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Garlic?
Reported side effects may include Gastrointestinal discomfort (heartburn, gas, nausea), Body and breath odor, Increased bleeding risk, Allergic reactions (contact dermatitis, rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Garlic and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。